Accuracy of exercise testing in the assessment of the severity of myocardial ischemia as determined by means of technetium-99m tetrofosmin SPECT scintigraphy

被引:14
|
作者
Galassi, AR
Azzarelli, S
Lupo, L
Mammana, C
Foti, R
Tamburino, C
Musumeci, S
Giuffrida, G
机构
[1] Ferrarotto Hosp, Inst Cardiol, Catania, Italy
[2] Univ Catania, Lecturership Med Stat, I-95124 Catania, Italy
[3] Univ Catania, Chair Nucl Med, I-95124 Catania, Italy
关键词
exercise testing; technetium-99m tetrofosmin single photon emission computed tomography myocardial scintigraphy; rate-pressure product; ST/heart rate index;
D O I
10.1067/mnc.2000.108731
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The separation of patients with suspected or known coronary artery disease into low- and high-risk subgroups by means of noninvasive testing is highly relevant in the selection of patients who require further diagnostic or therapeutic investigation. We evaluated whether exercise electrocardiographic variables during exercise testing might be a means of predicting the severity of myocardial ischemia as assessed,vith myocardial scintigraphy. Methods and Results. We retrospectively reviewed 816 consecutive patients (mean age, 57 +/- 10 Sears) who underwent exercise technetium-99m tetrofosmin single photon emission computed tomography (SPECT) for the assessment of suspected or known coronary artery disease, Eight independent significant predictors of the extent and severity of reversible perfusion defects (ischemic perfusion score), which when integrated in a diagnostic algorithm satisfactorily discriminated patients with no reversible perfusion defects (sensitivity, 75%; specificity, 80%) and patients with severe impaired myocardial perfusion (greater than or equal to 11 ischemic perfusion score; sensitivity, 77%; specificity, 82%), were identified by means of stepwise discriminant analysis. However, patients,vith mildly to moderately impaired myocardial perfusion (greater than or equal to1 but <11 ischemic perfusion score) were poorly discriminated (sensitivity, 50%; specificity, 78%), The set of variables that were significant (P <.0001) for prediction included sex, myocardial infarction, exercise angina, the maximal amount of ST segment depression, rate-pressure product threshold criteria, slope of ST segment depression, ST/heart rate index, and peak exercise heart rate. Conclusions. The results of the use of clinical and electrocardiographic exercise variables satisfactorily agrees with the results from scintigraphy only for patients with no reversible perfusion defects and with severely impaired myocardial perfusion. However, it fails as an approach with universal applicability.
引用
收藏
页码:575 / 583
页数:9
相关论文
共 50 条
  • [1] Accuracy of exercise testing in the assessment of the severity of myocardial ischemia as determined by means of technetium-99m tetrofosmin SPECT scintigraphy
    Alfredo R. Galassi
    Salvatore Azzarelli
    Lorenzo Lupo
    Carmelo Mammana
    Rosario Foti
    Corrado Tamburino
    Salvatore Musumeci
    Giuseppe Giuffrida
    Journal of Nuclear Cardiology, 2000, 7 : 575 - 583
  • [2] Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy
    Giordano, A
    Meduri, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (03) : 347 - 347
  • [3] Parathyroid scintigraphy: Comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies
    Aigner, RM
    Fueger, GF
    Nicoletti, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (06): : 693 - 696
  • [4] Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy
    Alessandro Giordano
    Guido Meduri
    European Journal of Nuclear Medicine, 1997, 24 : 347 - 347
  • [5] Technetium-99m tetrofosmin scintigraphy in pediatric osteogenic sarcoma
    Schillaci, O
    Spanu, A
    Scopinaro, F
    Monteleone, F
    Masala, S
    Tarantino, U
    Madeddu, G
    Simonetti, G
    ONCOLOGY REPORTS, 2003, 10 (03) : 605 - 608
  • [6] Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions
    Madariaga, P
    Almoguera, I
    Alonso, A
    Escat, JL
    Vegazo, O
    Martinez, ML
    Trampal, C
    Vazquez, JMP
    ANTICANCER RESEARCH, 1997, 17 (3B) : 1619 - 1621
  • [7] Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma
    Lee, JK
    Tsai, SC
    Ho, YJ
    Changlai, SP
    Kao, CH
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1509 - 1513
  • [8] Technetium-99m tetrofosmin scintigraphy in the diagnosis of breast cancer
    Vieira, MR
    Weinholtz, JHB
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (04): : 331 - 334
  • [9] EFFICACY OF TECHNETIUM-99M PYROPHOSPHATE MYOCARDIAL SCINTIGRAPHY
    KONDOS, G
    SHULRUFF, S
    PIETRAS, R
    CLINICAL RESEARCH, 1983, 31 (04): : A707 - A707
  • [10] No gender bias in referral for coronary angiography after myocardial perfusion scintigraphy with technetium-99m tetrofosmin
    Jeanine E. Roeters van Lennep
    Judocus J. J. Borm
    Aeilko H. Zwinderman
    Ernest K. J. Pauwels
    Albert V. G. Bruschke
    Ernst E. van der Wall
    Journal of Nuclear Cardiology, 1999, 6 : 596 - 604